NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 5 filers reported holding NEURODERM LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $584,000 | -5.8% | 15,000 | -27.6% | 0.00% | 0.0% |
| Q2 2017 | $620,000 | -91.2% | 20,731 | -92.2% | 0.00% | -92.3% |
| Q1 2017 | $7,024,000 | -24.7% | 264,571 | -37.1% | 0.01% | -35.0% |
| Q4 2016 | $9,331,000 | +369.4% | 420,299 | +336.9% | 0.02% | +400.0% |
| Q3 2015 | $1,988,000 | – | 96,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |